Patents by Inventor Yibing Yan

Yibing Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BELVARAFENIB FOR USE IN TREATMENT OF BRAIN CANCERS
    Publication number: 20240173329
    Abstract: Provided are methods for the use of belvarafenib to treat brain cancer including metastatic brain cancer carrying a BRAF mutation, a NRAS mutation, a KRAS mutation, or a combination thereof.
    Type: Application
    Filed: March 8, 2022
    Publication date: May 30, 2024
    Inventors: Joanne Adamkewicz, Michael John Dolton, Shiva Malek, Piia Thomas, Jennifer Eng-Wong, Yibing Yan, Young Hoon KIM, Young Gil AHN, Yu Yon KIM
  • BELVARAFENIB FOR USE IN CANCER TREATMENT
    Publication number: 20230233567
    Abstract: Provided are methods for the use of belvarafenib to treat cancer having at least one mutation selected from a BRAFV600E mutation, a KRASG12V mutation, a KRASG12D mutation, a KRASG12C mutation, a KRASG12R mutation, a KRASG13D mutation, a KRASQ61H mutation, a NRASG12D mutation, a NRASG13D mutation, a NRASQ61K mutation, a NRASQ61L mutation, a NRASQ61R mutation, and a NRASG12C mutation.
    Type: Application
    Filed: May 17, 2021
    Publication date: July 27, 2023
    Inventors: Tae Won KIM, Yoon-hee HONG, Young Su NOH, Matthew Tsn-Wei CHANG, Shiva MALEK, Yibing YAN, Ivana Yen Yen YEN
  • METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY
    Publication number: 20220016243
    Abstract: The present invention relates to methods, uses, and compositions for the treatment of cancer (e.g., a lung cancer; a cervical cancer; a breast cancer; a head and neck cancer; a liver cancer; a bladder cancer; a gastric cancer; an esophageal cancer; a pancreatic cancer; a kidney or renal cancer; a melanoma; an ovarian cancer; or a colorectal cancer). More specifically, the invention concerns the treatment of patients having cancer with an anti-TIGIT antagonist antibody, including treatment with an anti-TIGIT antagonist antibody in a combination therapy.
    Type: Application
    Filed: January 26, 2021
    Publication date: January 20, 2022
    Applicants: Genentech, Inc., Hoffmann-La Roche Inc.
    Inventors: Catherine LAI, Janet LAU, Anthony Jongha LEE, Shi LI, Yvonne Gail LIN-LIU, Christina Jeanne MATHENY, Diana MENDUS, Raymond D. MENG, Anh NGUYEN DUC, Jilpa Bhupendra PATEL, Thinh Quang PHAM, Isabelle Anne ROONEY, Heather Blythe STEVENS, Sarah Marie TROUTMAN, Lijia WANG, Yulei WANG, Patrick Georges Robert WILLIAMS, Benjamin WU, Yibing YAN, Aijing ZHANG, Xiaosong ZHANG, Marcus Dale BALLINGER, Hila BARAK, Elizabeth Alexandra BENNETT, Marcela Lucia CASTRO, Edward Namserk CHA, Hui Min Phyllis CHAN, Stephen CHUI, Christopher Roland COTTER, Viraj Vinay DEGAONKAR, Barbara Jennifer GITLITZ, Tien HOANG, Kimberly Mayumi KOMATSUBARA
  • METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
    Publication number: 20100216115
    Abstract: Disclosed herein are methods and compositions useful for identifying therapies likely to confer optimal clinical benefit for patients with cancer.
    Type: Application
    Filed: December 22, 2009
    Publication date: August 26, 2010
    Applicant: Genentech, Inc.
    Inventors: Yibing Yan, Paul J. Fielder, Qun Jenny Wu
  • Compounds and methods for the modulation of CD154
    Publication number: 20040072750
    Abstract: The invention relates to compounds that are capable of modulating CD154 mobilization and that are useful for stabilizing the thrombotic and/or coagulation process and/or reducing the activation of cells involved in an inflammatory response. The invention also relates to methods useful for identifying such compounds. The invention also relates to the treatment of platelets for transfusion with metalloproteinase inhibitors to treat or prevent inflammation. The present invention also includes compositions and methods to treat injury and disease related to such biological processes.
    Type: Application
    Filed: February 28, 2003
    Publication date: April 15, 2004
    Inventors: David Phillips, Yibing Yan, Lisa Alaimo, Srinivasa Prasad
  • Compounds and methods for the modulation of CD154
    Publication number: 20020165166
    Abstract: The present invention relates to compounds that are capable of modulating CD154 mobilization and that are useful for stabilizing the thrombotic process and reducing the activation of cells involved in an inflammatory response. The present invention also relates to methods useful for identifying such compounds. The present invention also relates to the treatment of platelets for transfusion with metalloproteinase inhibitors to treat or prevent inflammation. The present invention also includes compositions and methods to treat injury and disease related to such biological processes.
    Type: Application
    Filed: November 30, 2001
    Publication date: November 7, 2002
    Inventors: Yibing Yan, David Phillips, Lisa Alaimo, Patrick Andre, Veronica Alves